Mark Hayden is an associate in the New York office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on intellectual property litigation with a particular emphasis on representing clients in the life sciences industry. He has significant experience litigating under the Hatch-Waxman Act and has played key roles in fact and expert discovery, depositions, trial, and appellate proceedings.
Before attending law school, Mark worked in a research laboratory at Brigham & Women’s Hospital/Harvard Medical School focused on using next generation sequencing (NGS) technologies to elucidate the molecular and genetic underpinnings of cancers, gynecological diseases, and human developmental disorders.
In addition to his commercial work, Mark is actively involved in pro bono work, representing clients in probate guardianship and immigration proceedings, as well as providing guidance to non-profit organizations and small businesses on intellectual property-related matters.
Mark is also registered to practice before the U.S. Patent & Trademark Office.
Mark Hayden is an associate in the New York office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on intellectual property litigation with a particular emphasis on representing clients in the life sciences industry. He has significant experience litigating under the Hatch-Waxman Act and has played key roles in fact and expert discovery, depositions, trial, and appellate proceedings.
Before attending law school, Mark worked in a research laboratory at Brigham & Women’s Hospital/Harvard Medical School focused on using next generation sequencing (NGS) technologies to elucidate the molecular and genetic underpinnings of cancers, gynecological diseases, and human developmental disorders.
In addition to his commercial work, Mark is actively involved in pro bono work, representing clients in probate guardianship and immigration proceedings, as well as providing guidance to non-profit organizations and small businesses on intellectual property-related matters.
Mark is also registered to practice before the U.S. Patent & Trademark Office.
- J.D., Boston College Law School
Managing Editor, Boston College Law Review
- B.B.A., Finance, The College of William & Mary
Minor in Biochemistry; Research Fellow, Department of Neuroscience
- State Bar of New York
- U.S. Patent and Trademark Office
- J.D., Boston College Law School
Managing Editor, Boston College Law Review
- B.B.A., Finance, The College of William & Mary
Minor in Biochemistry; Research Fellow, Department of Neuroscience
- State Bar of New York
- U.S. Patent and Trademark Office
Select Publications
- Author, “The Burgeoning ‘Biorights Movement’: Its Legal Basis, What’s at Stake, and How to Respond,” Boston College Law Review, 2018
- Lead author, “Clinical, Pathologic, Cytogenetic, and Molecular Profiling in Self-Identified Black Women with Uterine Leiomyomata,” 222–223 Cancer Genetics 1–8, 2018
- Co-author, “The Genomic Landscape of Balanced Cytogenetic Abnormalities Associated with Human Congenital Anomalies,” 49(1) Nature Genetics 36–45, 2017
- Co-author, “Structural Chromosomal Rearrangements Require Nucleotide-Level Resolution: Lessons from Next-Generation Sequencing in Prenatal Diagnosis,” 99(5) American Journal of Human Genetics 1015–1033, 2016
Select Publications
- Author, “The Burgeoning ‘Biorights Movement’: Its Legal Basis, What’s at Stake, and How to Respond,” Boston College Law Review, 2018
- Lead author, “Clinical, Pathologic, Cytogenetic, and Molecular Profiling in Self-Identified Black Women with Uterine Leiomyomata,” 222–223 Cancer Genetics 1–8, 2018
- Co-author, “The Genomic Landscape of Balanced Cytogenetic Abnormalities Associated with Human Congenital Anomalies,” 49(1) Nature Genetics 36–45, 2017
- Co-author, “Structural Chromosomal Rearrangements Require Nucleotide-Level Resolution: Lessons from Next-Generation Sequencing in Prenatal Diagnosis,” 99(5) American Journal of Human Genetics 1015–1033, 2016
- Privacy Policy
- Terms of Use
- Accessibility